Search Within

Department of Medicine

Formats
  1. Journal Article (19620)
  2. Meeting Abstract (16084)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (237)
  10. Miscellaneous (91)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22367)
  2. Hematologic Malignancies, Division of (13308)
  3. Center for Hematologic Malignancies (11082)
  4. GSK Faculty (10658)
  5. Survivorship Research (9352)
  6. Division of Subspecialty Medicine (7560)

More Groups

People
  1. Robert Motzer (1251)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1158)
  2. 2024 (2293)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1411)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (904)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2898)
  5. Oxford University Press (2304)
  6. Nature Publishing Group (2122)

More Publishers

Results (39711)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized phase III clinical trial of acupuncture for chemotherapy-induced peripheral neuropathy in survivors of cancer
    Meeting Abstract

    Lopez-Nieves, I.; Chiang, C.; Han, K.; Piulson, L.; Seluzicki, C.; Weitzman, M.; Zhang, Y. L.; Zhi, I.; Bao, T.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    D'Angelo, S. P.; Rosenbaum, E.; Gularte Mérida, R.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • NOTOS: A pivotal study of navtemadlin, a first-in-class mouse double minute 2 inhibitor (MDM2i), in patients (pts) with TP53 wild-type (TP53(WT)) Merkel cell carcinoma (MCC) for whom anti PD-1/L1 therapy has failed
    Meeting Abstract

    Wong, M. K. K.; Burgess, M. A.; Chandra, S.; Fecher, L. A.; Gaudy-Marqueste, C.; Silk, A. W.; Hanna, G. J.; Lebbe, C.; Quéreux, G.; Rabinowits, G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • INSIGHT: A phase 3, randomized, multicenter, open-label study of ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib harboring KIT exon 11 + 17 and/or 18 mutations
    Meeting Abstract

    George, S.; Blay, J. Y.; Chi, P.; Jones, R. L.; Serrano, C.; Somaiah, N.; Reichmann, W.; Sprott, K.; Achour, H.; Sherman, M. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • ENVASARC: A pivotal trial of envafolimab and envafolimab in combination with ipilimumab in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy
    Meeting Abstract

    Riedel, R. F.; Chawla, S. P.; Druta, M.; Jones, R. L.s; Schuetze, S.; Lam, J.; Zhuang, D.; Freddo, J. L.; Adams, B. J.; Theuer, C. P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Alliance A092104: A randomized phase 2/3 study of olaparib plus temozolomide versus investigator's choice for the treatment of patients with advanced uterine leiomyosarcoma after progression on prior chemotherapy
    Meeting Abstract

    Lacuna, K. P.; Mandrekar, S. J.; Allred, J. B.; Berg, S. A.; Hensley, M. L.; Van Tine, B. A.; George, S.; Schwartz, G. K.; Ingham, M.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 2, open-label, adaptive, dose-ranging study with long-term extension to evaluate the safety, tolerability, efficacy, and pharmacokinetics of intra-articular AMB-05X injections in patients with tenosynovial giant cell tumor
    Meeting Abstract

    Gelderblom, H.; Bhadri, V.; Randall, R. L.; Scharschmidt, T.; Tap, W. D.; Alani, L.; Johnson, K.; Leyva, S.; Nguyen, D. D.; Nguyen, T.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Betof Warner, A.; Postow, M. A.; Panageas, K.; Smithy, J. W.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Durvalumab with chemotherapy as first line treatment in advanced pleural mesothelioma: A phase 3, randomised trial (DREAM3R)
    Meeting Abstract

    Forde, P. M.; Nowak, A. K.; Hughes, B. G. M.; Kok, P. S.; Brown, C.; Sun, Z.; Anagnostou, V.; O'Byrne, K.; Yip, S.; Cook, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) for patients with pleural metastases from thymic malignancies
    Meeting Abstract

    Rimner, A.; Huang, J.; Pagano, A.; Ginsberg, M. S.; Chang, J. C.; Riely, G. J.; Simone, C. B.; Gomez, D. R.; Shepherd, A.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save